BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 17133470)

  • 1. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
    Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
    Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.
    Andrade RJ; Lucena MI; Fernández MC; Pelaez G; Pachkoria K; García-Ruiz E; García-Muñoz B; González-Grande R; Pizarro A; Durán JA; Jiménez M; Rodrigo L; Romero-Gomez M; Navarro JM; Planas R; Costa J; Borras A; Soler A; Salmerón J; Martin-Vivaldi R;
    Gastroenterology; 2005 Aug; 129(2):512-21. PubMed ID: 16083708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain.
    Lucena MI; Andrade RJ; Fernández MC; Pachkoria K; Pelaez G; Durán JA; Villar M; Rodrigo L; Romero-Gomez M; Planas R; Barriocanal A; Costa J; Guarner C; Blanco S; Navarro JM; Pons F; Castiella A; Avila S;
    Hepatology; 2006 Oct; 44(4):850-6. PubMed ID: 17006920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
    Björnsson E; Jacobsen EI; Kalaitzakis E
    J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiosyncratic drug hepatotoxicity: a 2008 update.
    Andrade RJ; López-Ortega S; López-Vega MC; Robles M; Cueto I; Lucena MI
    Expert Rev Clin Pharmacol; 2008 Mar; 1(2):261-76. PubMed ID: 24422651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiosyncratic drug-induced liver injury: an overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2007 Nov; 6(6):673-84. PubMed ID: 17967156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin associated liver disease.
    Clarke AT; Mills PR
    Dig Liver Dis; 2006 Oct; 38(10):772-7. PubMed ID: 16777499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced liver injury associated with statins.
    Russo MW; Scobey M; Bonkovsky HL
    Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital admissions for drug-induced liver injury: clinical features, therapy, and outcomes.
    Hou FQ; Zeng Z; Wang GQ
    Cell Biochem Biophys; 2012 Nov; 64(2):77-83. PubMed ID: 22806342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
    Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
    J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amoxicillin-Clavulanate-Induced Liver Injury.
    deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
    Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury.
    Jinjuvadia K; Kwan W; Fontana RJ
    Am J Gastroenterol; 2007 Nov; 102(11):2437-43. PubMed ID: 17662100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
    Medina-Cáliz I; Sanabria-Cabrera J; Villanueva-Paz M; Aukštikalnė L; Stephens C; Robles-Díaz M; Pinazo-Bandera JM; García-Cortes M; Conde I; Soriano G; Bessone F; Hernandez N; Nunes V; Paraná R; Lucena MI; Andrade RJ; Niu H; Alvarez-Alvarez I
    Arch Toxicol; 2024 Jan; 98(1):303-325. PubMed ID: 38051367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
    Rahier JF; Rahier J; Leclercq I; Geubel AP
    Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.
    Medina-Caliz I; Robles-Diaz M; Garcia-Muñoz B; Stephens C; Ortega-Alonso A; Garcia-Cortes M; González-Jimenez A; Sanabria-Cabrera JA; Moreno I; Fernandez MC; Romero-Gomez M; Navarro JM; Barriocanal AM; Montane E; Hallal H; Blanco S; Soriano G; Roman EM; Gómez-Dominguez E; Castiella A; Zapata EM; Jimenez-Perez M; Moreno JM; Aldea-Perona A; Hernández-Guerra M; Prieto M; Zoubek ME; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2016 Sep; 65(3):532-42. PubMed ID: 27184533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions.
    Pinazo-Bandera JM; Niu H; Alvarez-Alvarez I; Medina-Cáliz I; Del Campo-Herrera E; Ortega-Alonso A; Robles-Díaz M; Hernández N; Paraná R; Nunes V; Girala M; Bessone F; Lucena MI; Andrade RJ; García Cortés M
    Pharmacol Res; 2024 May; 203():107183. PubMed ID: 38631619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.